Premium
A PHASE II STUDY OF ANTI‐PD‐1 SINTILIMAB IN COMBINATION WITH CHIDAMIDE AND AZACITIDINE IN REFRACTORY AND RELAPSED PERIPHERAL T‐CELL LYMPHOMA
Author(s) -
Ying Z.,
Song Y.,
Wang X.,
Lin N.,
Xie Y.,
Du T.,
Tang Y.,
Zhu J.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.168_2880
Subject(s) - medicine , azacitidine , oncology , refractory (planetary science) , immunotherapy , cancer , cancer research , immunology , biology , dna methylation , biochemistry , gene expression , gene , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom